Skip to main content
Alligator Bioscience logo

Alligator Bioscience — Investor Relations & Filings

Ticker · ATORX ISIN · SE0024173637 LEI · 549300E15VI0MB7LXV19 ST Manufacturing
Open in API
Filings indexed 612 across all filing types
Latest filing 2021-12-30 Declaration of Voting R…
Country SE Sweden
Listing ST ATORX

About Alligator Bioscience

https://alligatorbioscience.se/en/

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.

Recent filings

Filing Released Lang Actions
Ändring av antalet aktier och röster i Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text announces a change in the total number of shares and votes for Alligator Bioscience AB following the completion of a rights issue and a directed new share issue. This directly relates to changes in the company's capital structure and share count. The key phrases are 'Ändring av antalet aktier och röster' (Change in the number of shares and votes) and the description of completed share issues ('företrädesemission av aktier' and 'riktade nyemissionen av aktier'). This aligns precisely with the definition for 'Share Issue/Capital Change' (SHA). The document is short and appears to be a formal regulatory disclosure regarding capital structure changes, not a full report or a mere announcement of a report's publication.
2021-12-30 Swedish
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly details a change in shareholding percentage for a holder (Nordnet AB (publ)) in an issuer (Alligator Bioscience AB). It shows 'Before the transaction' and 'After the transaction' share quantities and percentages, crossing a threshold ('Limit for number of shares 5 %'). The title/context implies a notification regarding major shareholding. This directly corresponds to the definition of Major Shareholding Notification (MRQ). The publication date is 27/12/2021.
2021-12-27 English
Sista dag för handel med BTA i Alligator
Capital/Financing Update Classification · 1% confidence The document is a press release written in Swedish concerning the completion of a rights issue ('Företrädesemissionen') for Alligator Bioscience AB. Key elements include the registration of the issue with the Swedish Companies Registration Office ('Bolagsverket'), the final trading day for temporary shares ('BTA'), the amount raised (approx. 257 MSEK), and resulting changes in share capital and total number of shares. This announcement details a significant change in the company's capital structure resulting from a financing activity (the rights issue). This aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV). Since it is a specific announcement about capital structure change due to fundraising, CAP is the most appropriate classification.
2021-12-16 Swedish
Last day of trading in paid subscription shares (Sw. BTA) in Alligator
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the final steps of a rights issue, specifically that the paid subscription shares (BTA) will be replaced by ordinary shares and setting the last trading day for BTA. It details the capital increase resulting from the rights issue and references the Prospectus previously published. This type of announcement, concerning fundraising, capital structure changes, and the conclusion of a financing event, aligns directly with the definition of a Capital/Financing Update. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific corporate action update.
2021-12-16 English
Alligator carries out a directed issue of shares to guarantors in connection with the completed rights issue
Share Issue/Capital Change Classification · 1% confidence The document announces the completion of a rights issue and a subsequent directed issue of shares to guarantors in exchange for guarantee commission. This action involves the issuance of new ordinary shares, an increase in the total number of shares, and an increase in share capital. This directly relates to changes in the company's capital structure and the issuance of new shares. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). It is not a general financing update (CAP) because it is a specific transaction detail following a rights issue, nor is it a transaction in own shares (POS) as it involves issuing *new* shares to third parties (guarantors) as payment, rather than repurchasing or selling treasury stock.
2021-12-02 English
Alligator genomför riktad nyemission av aktier till garanter i samband med den genomförda företrädesemissionen
Capital/Financing Update Classification · 1% confidence The document is a press release written in Swedish announcing that Alligator Bioscience AB has completed a rights issue and is now conducting a directed new share issue (Ersättningsemissionen) to the guarantors as compensation. This action involves the issuance of new shares and changes to the capital structure (increase in shares and share capital). This directly relates to fundraising, financing activities, or capital structure changes. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate finance action.
2021-12-02 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.